Bioventus (BVS) Short-term Investments (2021 - 2022)
Bioventus' (BVS) quarterly Short-term Investments came in at $23000.0 in Q4 2022, down 99.56% YoY from $5.3 million in Q4 2021, and little changed on a QoQ basis from $23000.0 in Q4 2022.
Bioventus (BVS) Short-term Investments (2021 - 2022) Analysis & Trends
Bioventus (BVS) has 2 years of Short-term Investments data on file, last reported at $23000.0 in Q4 2022.
- Quarterly Short-term Investments fell 99.56% year-over-year to $23000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $23000.0 (down 99.56% YoY) and the FY2022 annual result came in at $23000.0, down 99.56% from the prior year.
- Short-term Investments steadied at $23000.0 in Q4 2022, from $23000.0 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $5.3 million in Q4 2021 to a low of $23000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 23,000.00 |
| Oct 1, 2022 | 23,000.00 |
| Apr 2, 2022 | 5.28 Mn |
| Dec 31, 2021 | 5.28 Mn |
| Jul 3, 2021 | 2.00 Mn |
| Apr 3, 2021 | 5.21 Mn |